Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Equity Ratio (2016 - 2026)

Cryo Cell International's Equity Ratio history spans 17 years, with the latest figure at 0.3 for Q1 2026.

  • Quarterly results put Equity Ratio at 0.3 for Q1 2026, down 32.75% from a year ago — trailing twelve months through Feb 2026 was 0.3 (down 32.75% YoY), and the annual figure for FY2025 was 0.3, down 47.51%.
  • Equity Ratio for Q1 2026 was 0.3 at Cryo Cell International, roughly flat from 0.3 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.08 in Q2 2022 to a low of 0.3 in Q1 2026.
  • The 5-year median for Equity Ratio is 0.17 (2024), against an average of 0.12.
  • The sharpest move saw Equity Ratio surged 581.68% in 2022, then plummeted 65489.26% in 2024.
  • Year by year, Equity Ratio stood at 0.02 in 2022, then plummeted by 626.05% to 0.17 in 2023, then fell by 19.81% to 0.2 in 2024, then plummeted by 47.51% to 0.3 in 2025, then decreased by 0.26% to 0.3 in 2026.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.3, 0.3, and 0.23 for Q1 2026, Q4 2025, and Q3 2025 respectively.